MAGGIO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 525
EU - Europa 359
AS - Asia 89
AF - Africa 38
OC - Oceania 1
SA - Sud America 1
Totale 1.013
Nazione #
US - Stati Uniti d'America 524
IT - Italia 73
SE - Svezia 73
GB - Regno Unito 67
DE - Germania 57
VN - Vietnam 30
CN - Cina 26
IE - Irlanda 25
IN - India 24
CI - Costa d'Avorio 18
CH - Svizzera 16
TG - Togo 13
FR - Francia 10
RU - Federazione Russa 9
FI - Finlandia 6
BE - Belgio 5
BG - Bulgaria 5
JO - Giordania 5
NG - Nigeria 4
UA - Ucraina 4
EE - Estonia 3
ZA - Sudafrica 3
AU - Australia 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
IR - Iran 1
KR - Corea 1
MD - Moldavia 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
Totale 1.013
Città #
Chandler 93
Southend 59
Fairfield 57
Ashburn 39
Princeton 31
Seattle 26
Dublin 25
Wilmington 25
Houston 22
Woodbridge 21
Abidjan 18
Ann Arbor 16
Bern 16
Cambridge 14
Lomé 13
Berlin 12
Turin 12
Bologna 11
Florence 10
Beijing 8
Milan 7
Westminster 7
Helsinki 6
Amman 5
Des Moines 5
Sofia 5
Abeokuta 4
Bentivoglio 4
Bremen 4
Brussels 4
Redmond 4
San Diego 4
Boardman 3
Jinan 3
London 3
Nanjing 3
Saint Petersburg 3
San Francisco 3
San Jose 3
Bühl 2
Changsha 2
Frankfurt am Main 2
Hangzhou 2
New York 2
Noicattaro 2
Padova 2
Shenyang 2
Boydton 1
Brescia 1
Canberra 1
Cesena 1
Chisinau 1
Copenhagen 1
Council Bluffs 1
Dallas 1
Den Haag 1
Forlimpopoli 1
Forlì 1
Fremont 1
Guangzhou 1
Haikou 1
Istanbul 1
Kuban 1
Lanzhou 1
Leawood 1
Magdeburg 1
Magenta 1
Manchester 1
Medford 1
Mehr 1
Monmouth Junction 1
Montreal 1
Nanchang 1
Oklahoma City 1
Olalla 1
Oslo 1
Paris 1
Pavia 1
Radcliffe 1
Ravenna 1
Sibiu 1
Singapore 1
Taiyuan 1
Zhengzhou 1
Totale 661
Nome #
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 160
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 106
ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors—A systematic review and meta-analysis of real world data 106
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 101
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations 77
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis. 72
Therapeutic options in lung neuroendocrine tumors: between established concepts and new hopes 61
Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia 54
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 51
The functioning side of the pancreas: a review on insulinomas 50
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review 50
Third-and later-line treatment in advanced or metastatic gastric cancer: A systematic review and meta-analysis 42
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 31
Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: A systematic review 31
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light 31
Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas 30
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report 22
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma 5
Totale 1.080
Categoria #
all - tutte 3.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020160 15 3 0 6 11 22 19 25 18 23 18 0
2020/2021136 22 1 4 1 16 6 5 4 17 15 3 42
2021/2022255 4 5 9 7 24 5 6 30 20 31 74 40
2022/2023418 33 44 13 52 30 38 17 31 93 12 29 26
2023/202487 13 17 6 8 4 15 2 10 2 8 2 0
Totale 1.080